ifosfamide has been researched along with Hematologic Malignancies in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Major treatment-related adverse events were grade 3 or more hematologic toxicities, which included lymphopenia corresponding to dose-limiting toxicity." | 2.75 | Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study. ( Hosone, M; Isobe, Y; Katsuoka, Y; Komatsu, N; Oshimi, K; Shimizu, S; Sugimoto, K; Tsukune, Y; Yasuda, H, 2010) |
| "Ifosfamide is an alkylating agent with a broad spectrum of activity in solid tumors and hematological malignancies." | 2.42 | Ifosfamide in hematological malignancies of adults. ( Elice, F; Rodeghiero, F, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, S | 1 |
| Tanaka, E | 1 |
| Tamai, Y | 1 |
| Tsukune, Y | 1 |
| Isobe, Y | 1 |
| Yasuda, H | 1 |
| Shimizu, S | 1 |
| Katsuoka, Y | 1 |
| Hosone, M | 1 |
| Oshimi, K | 1 |
| Komatsu, N | 1 |
| Sugimoto, K | 1 |
| Rodeghiero, F | 1 |
| Elice, F | 1 |
| Dazzi, C | 1 |
| Cariello, A | 1 |
| Rosti, G | 1 |
| Monti, G | 1 |
| Sebastiani, L | 1 |
| Argnani, M | 1 |
| Nicoletti, P | 1 |
| Tienghi, A | 1 |
| Leoni, M | 1 |
| Fiorentini, G | 1 |
| Turci, D | 1 |
| Giovanis, P | 1 |
| De Giorgi, U | 1 |
| Marangolo, M | 1 |
1 review available for ifosfamide and Hematologic Malignancies
| Article | Year |
|---|---|
Ifosfamide in hematological malignancies of adults.
Topics: Adult; Antineoplastic Agents, Alkylating; Burkitt Lymphoma; Hematologic Neoplasms; Hodgkin Disease; | 2003 |
1 trial available for ifosfamide and Hematologic Malignancies
| Article | Year |
|---|---|
Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Female; Hematologic Neopl | 2010 |
2 other studies available for ifosfamide and Hematologic Malignancies
| Article | Year |
|---|---|
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dendritic Cells | 2019 |
Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combin | 1999 |